PFBT
CSTL icon

Parkside Financial Bank & Trust’s Castle Biosciences CSTL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596 Hold
25
– – ﹤0.01% 2566
2026
Q1 		$614 Hold
25
– – ﹤0.01% 2511
2025
Q4 		$973 Buy
+25
New +$806 ﹤0.01% 2356
2025
Q3 		– Sell
-25
Closed -$511 – 2734
2025
Q2 		$511 Buy
25
+5
+25% +$93 ﹤0.01% 2537
2025
Q1 		$401 Buy
+20
New +$495 ﹤0.01% 2536

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's CSTL Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Castle Biosciences (CSTL) position steady in Q2 2026 at 25 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

Parkside Financial Bank & Trust first reported a position in CSTL in Q1 2025 and has held it in 5 quarters since. The position peaked at $973 in Q4 2025. 176 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Parkside Financial Bank & Trust held 25 shares of Castle Biosciences worth $596 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Castle Biosciences share count unchanged in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2566 holding.
  • Parkside Financial Bank & Trust first reported a position in Castle Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Castle Biosciences position peaked at $973 in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.